Kinase-dependent differentiation of a retinal ganglion cell precursor

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 1, 2006, Pages 427-438

  Frassetto, Laura J ^a   Schlieve, Christopher R ^a   Lieven, Christopher J ^a   Utter, Amy A ^a   Jones, Mathew V ^a   Agarwal, Neeraj ^b   Levin, Leonard A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE; ROTENONE; STAUROSPORINE; THAPSIGARGIN; BIOLOGICAL MARKER; ENZYME INHIBITOR; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NMDA RECEPTOR A1; PROTEIN KINASE C; THY 1 ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DEVELOPMENT; RETINA GANGLION CELL; ANIMAL; CELL COUNT; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROPHYSIOLOGY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RAT; STEM CELL;

ANIMALS; ANTIGENS, THY-1; BIOLOGICAL MARKERS; CELL COUNT; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOBLOTTING; ION CHANNELS; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL GANGLION CELLS; STAUROSPORINE; STEM CELLS;

EID: 33644844271     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0340     Document Type: Article

References (27)

1. Levin LA. Models of neural injury. J Glaucoma. 2001;10(5 suppl 1):S19-S21.
2. Leahy KM, Ornberg RL, Wang Y, et al. Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b. Exp Eye Res. 2004;79:131-140.
3. Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron. 1988;1:791-803.
4. Lindqvist N, Vidal-Sanz M, Hallbook F. Single cell RT-PCR analysis of tyrosine kinase receptor expression in adult rat retinal ganglion cells isolated by retinal sandwiching. Brain Res Brain Res Protoc. 2002;10:75-83.
5. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 1976;73:2424-2428.
6. Pleasure SJ, Page C, Lee VM. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci. 1992;12:1802-1815.
7. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973;33:2643-2652.
8. Krishnamoorthy RR, Agarwal P, Prasanna G, et al. Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res. 2001;86:1-12.
9. Moorhouse AJ, Li S, Vickery RM, Hill MA, Morley JW. A patch-clamp investigation of membrane currents in a novel mammalian retinal ganglion cell line. Brain Res. 2004;1003:205-208.
10. Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A. 2004;58:167-176.
11. Zhang H, Shi X, Hampong M, Blanis L, Pelech S. Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J Biol Chem. 2001;276:6905-6908.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
13. Marshall NJ, Goodwin CJ, Holt SJ. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 1995;5:69-84.
14. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J. 2003;371:199-204.
15. Pelech S. Tracking cell signaling protein expression and phosphorylation by innovative proteomic solutions. Curr Pharm Biotechnol. 2004;5:69-77.
16. Takahashi N, Shimizu T, Takeda K. Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells. Prostate. 2000;44:328-333.
17. Shimizu T, Takahashi N, Tachibana K, Takeda K. Complex regulation of CDK2 and G1 arrest during neuronal differentiation of human prostatic cancer TSU-Prl cells by staurosporine. Anticancer Res. 2001;21:893-898.
18. Okazaki T, Kato Y, Mochizuki T, Tashima M, Sawada H, Uchino H. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds. Exp Hematol. 1988;16:42-48.
19. Xie HQ, Adler R. Green cone opsin and rhodopsin regulation by CNTF and staurosporine in cultured chick photoreceptors. Invest Ophthalmol Vis Sci. 2000;41:4317-4323.
20. Hashimoto S, Hagino A. Staurosporine-induced neurite outgrowth in PC12h cells. Exp Cell Res. 1989;184:351-359.
21. Hashimoto S, Hagino A. Blockage of nerve growth factor action in PC12h cells by staurosporine, a potent protein kinase inhibitor. J Neurochem. 1989;53:1675-1685.
22. Raffioni S, Bradshaw RA. Staurosporine causes epidermal growth factor to induce differentiation in PC12 cells via receptor upregulation. J Biol Chem. 1995;270:7568-7572.
23. Reuter H, Bouron A, Neuhaus R, Becker C, Reber BF. Inhibition of protein kinases in rat pheochromocytoma (PC12) cells promotes morphological differentiation and down-regulates ion channel expression. Proc R Soc Lond B Biol Sci. 1992;249:211-216.
24. Kukkonen JP, Shariatmadari R, Courtney MJ, Akerman KE. Localization of voltage-sensitive Ca2+ fluxes and neuropeptide Y immunoreactivity to varicosities in SH-SY5Y human neuroblastoma cells differentiated by treatment with the protein kinase inhibitor staurosporine. Eur J Neurosci. 1997;9:140-150.
25. Jalava A, Akerman K, Heikkila J. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. J Cell Physiol. 1993;155:301-312.
26. Jalava A, Heikkila J, Lintunen M, Akerman K, Pahlman S. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA). FEBS Lett. 1992;300:114-118.
27. Prince JA, Oreland L. Staurosporine differentiated human SH-SY5Y neuroblastoma cultures exhibit transient apoptosis and trophic factor independence. Brain Res Bull. 1997;43:515-523.